Lidia Fonseca
Known title: Executive Vice PresidentCIK: 0001454944
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Pfizer Declares 352nd Straight Dividend, Holds Steady Amid Vaccine Selloff. Pfizer announced its 352nd consecutive quarterly dividend, keeping a yield of about 5.4%. The company’s share price has stayed flat even as other vaccine makers like Novavax and Moderna fell. A new approval for the drug Tukysa could alter the company’s outlook, and analysts are watching the upcoming Q3 2026 earnings report for more detail.
Transaction History
| MDT | ▼ Sell | Tax Withholding | 207 | $17K | 4/28/2026 | View on chart |
| MDT | ▲ Buy | Grant | 2,111 | $0 | 4/27/2026 | View on chart |
| PFE | ▲ Buy | Option Exercise | 56,888 | $1.9M | 2/25/2026 | View on chart |
| PFE | ▼ Sell | Tax Withholding | 1,058 | $29K | 2/25/2026 | View on chart |
| PFE | ▼ Sell | Tax Withholding | 54,066 | $1.5M | 2/25/2026 | View on chart |
| MDT | ▼ Sell | Tax Withholding | 216 | $18K | 4/29/2025 | View on chart |
| MDT | ▲ Buy | Grant | 2,083 | $175K | 4/28/2025 | View on chart |
| PFE | ▲ Buy | Option Exercise | 72,629 | $2.3M | 2/27/2025 | View on chart |
| PFE | ▼ Sell | Tax Withholding | 1,683 | $44K | 2/27/2025 | View on chart |
| PFE | ▼ Sell | Tax Withholding | 68,022 | $1.8M | 2/27/2025 | View on chart |
| MDT | ▼ Sell | Tax Withholding | 162 | $13K | 5/1/2024 | View on chart |
| MDT | ▲ Buy | Grant | 2,165 | $175K | 4/29/2024 | View on chart |
| MDT | ▲ Buy | Grant | 1,624 | $147K | 5/1/2023 | View on chart |
| PFE | ▼ Sell | Tax Withholding | 6,680 | $352K | 1/31/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
MiniMed completes separation from Medtronic
Medtronic has finalized the separation of its MiniMed insulin pump business, which is now operating as an independent company with a new board of directors. This corporate restructuring marks a significant shift in Medtronic's portfolio structure. Meanwhile, the company was named to the TIME Best Inventions of 2026 list for its Stealth AXiS surgical system and Corsano wearable, highlighting continued innovation in its remaining product lines.
MiniMed completes separation from Medtronic. Medtronic has finalized the separation of its MiniMed insulin pump business, which is now operating as an independent company with a new board of directors. This corporate restructuring marks a significant shift in Medtronic's portfolio structure. Meanwhile, the company was named to the TIME Best Inventions of 2026 list for its Stealth AXiS surgical system and Corsano wearable, highlighting continued innovation in its remaining product lines.